Liberta Co.,Ltd. (4935.T)
Tokyo, JP
Liberta Co.,Ltd., established in Tokyo, Japan, in 1997, operates globally, focusing on the development and sale of a wide array of goods. Its primary offerings include beauty products, everyday household items, and specialized performance apparel. The company markets its beauty line through popular brands like Baby Foot, Quick Beauty, DENTISTE, Slowbliss, Dext, and COSCOS. For household needs, it offers brands such as KABIDASH, Kabi Tornado, SHWATCH, and Mama La Clean. Functional clothing is provided under names including FREEZE TECH, heatmaster, DEODRIZETECH, and ThermOne. Additionally, Liberta distributes watches from Luminox and Libenham, as well as various food and general merchandise items like ThinOptics and ATHMEAL. Beyond its product portfolio, the company is also active in public relations, marketing, and direct-to-consumer sales, utilizing its own e-commerce platforms and major online marketplaces like Rakuten Ichiba. These products reach consumers through both physical retail outlets and diverse online channels.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.19% | -13.95% | -20.06% | -35.73% | -30.11% | -19.81% | -2.26% | +257.73% | +138.71% | +58.90% | +58.90% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+16.2% ★ Q1'26: +16.0% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+317.3% ★ Q1'26: -90.9% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%-2.1% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+1.3% Q1'26: -22.4% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+3.0% Q1'26: -28.9% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+1.8% Q1'26: +0.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×11.05× Q1'26: -2.58× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
5.11B
est: 4.90B (+4.3%)
|
5.03B
est: 5.48B (-8.2%)
|
6.64B
est: 5.87B (+13.1%)
|
7.09B
est: 7.53B (-5.8%)
|
8.64B
est: 9.23B (-6.4%)
|
10.03B
est: 10.48B (-4.2%)
|
11.62B
11.62B – 11.62B
+10.9% YoY
|
| EBITDA |
284.08M
est: 229.36M (+23.9%)
|
286.75M
est: 256.51M (+11.8%)
|
308.33M
est: 274.76M (+12.2%)
|
318.19M
est: 352.23M (-9.7%)
|
259.91M
est: 397.90M (-34.7%)
|
372.86M
est: 451.81M (-17.5%)
|
501.10M
501.10M – 501.10M
+10.9% YoY
|
| EBIT |
270.77M
est: 171.63M (+57.8%)
|
274.85M
est: 191.95M (+43.2%)
|
217.81M
est: 205.61M (+5.9%)
|
180.00M
est: 263.58M (-31.7%)
|
80.26M
est: 249.92M (-67.9%)
|
133.22M
est: 283.78M (-53.1%)
|
314.74M
314.74M – 314.74M
+10.9% YoY
|
| Net Income |
155.23M
est: 134.50M (+15.4%)
|
200.23M
est: 194.74M (+2.8%)
|
114.51M
est: 246.04M (-53.5%)
|
111.33M
est: 196.83M (-43.4%)
|
-21.17M
est: 126.90M (-116.7%)
|
46.33M
est: 183.06M (-74.7%)
|
218.58M
218.58M – 218.58M
+19.4% YoY
|
| SGA |
1.89B
est: 1.82B (+4.1%)
|
1.89B
est: 2.03B (-7.1%)
|
2.41B
est: 2.18B (+10.7%)
|
2.64B
est: 2.79B (-5.2%)
|
3.22B
est: 3.46B (-7.1%)
|
3.94B
est: 3.93B (+0.2%)
|
4.36B
4.36B – 4.36B
+10.9% YoY
|
| EPS |
5.92
est: 22.55 (-73.7%)
|
6.84
est: 32.65 (-79.1%)
|
3.85
est: 41.25 (-90.7%)
|
3.75
est: 33.00 (-88.6%)
|
-0.70
est: 4.18 (-116.8%)
|
1.54
est: 6.03 (-74.5%)
|
7.20
7.20 – 7.20
+19.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C- | 1/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akio Tsutsui | MD & Director | — | male |
| Shunsaku Nita | Senior MD & Director | — | male |
| Toru Sato | President, Chief Executive Officer & Chairman | — | male |
| Toyokazu Yamazaki | Senior Executive Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4935.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
